|
|
|
|
|
| 09.03.03 |
|
INTERNATIONAL PROGNOSTIC INDEX (IPI)
|
|
The IPI, an updated staging system for myeloma is a collaborative research initiative with nearly 20 institutions from around the world.
|
|
|
|
| |
 |
|
|
| 05.13.03 |
|
FDA Approves VELCADE for Myeloma Treatment
|
|
The first treatment in more than a decade to be approved for patients with multiple myeloma.
|
|
|
|
| |
|
|
|
| 05.08.03 |
|
New trial opens with VELCADE as front-line therapy
|
|
Investigator-initiated Phase II Trial of PS-341 Alone and in Combination with Dexamethasone in Previously Untreated Multiple Myeloma Patients.
|
|
|
|
| |
|
|
|
| 05.07.03 |
|
Phase III Revimid Study Sites Now Open
|
|
Celgene Corporation and Pharmanet are conducting a Phase III Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects with Multiple Myeloma.
|
|
|
|
| |
|
|
|
| 06.19.03 |
|
FDA Approves Supplemental New Drug Application for TRISENOX(R)
|
|
Cell Therapeutics received approval of its supplemental new drug application from the FDA just three months after submitting the application.
|
|
|
|
| |
|
|
|
| 04.10.03 |
|
Pharmacyclics Reports Novel Mechanism and Diverse Potential Uses of Xcytrin in Cancer
|
|
The ability of Xcytrin to inhibit cellular respiration results in the generation of reactive oxygen species (ROS), which can selectively destroy cancer cells via the induction of programmed cell death (apoptosis).
|
|
|
|
| |
|
|
|
| 04.02.03 |
|
Tests Show Repifermin Prevents Chemotherapy Damage
|
|
It significantly reduces chemotherapy's destruction of fast-growing cells lining the mouth, throat and digestive tract, thus reducing mucositis.
|
|
|
|
| |
|
|
|
| 06.01.03 |
|
Latest Myeloma Scientific Abstracts
|
|
Abstracts published within the last two months, provided by the Association of Cancer Online Resources (ACOR)
|
|
|
|
| |
|
|
|
| 06.01.03 |
|
Latest News Gathered From The Internet
|
|
Courtesy of the Association Of Cancer Online Resources (ACOR)
|
|
|
|
| |
|
|
|
|
|
It is the IMF's goal to provide the most current, up-to-date information to our members. You'll find the latest news about the recent developments in the treatment, management and prevention of myeloma right here. Please note that some article links may be time sensitive, and therefore, no longer active or available. 
